Pin your most used calculators here by clicking the star in the dropdown.
ELTS Score (CML)
years
cm
%
x10⁹/L
Clinical Context & Background
The ELTS score predicts the risk of dying from CML-related causes in patients treated with Tyrosine Kinase Inhibitors (TKIs). It discriminates leukemia-specific survival better than the Sokal score in the modern TKI era.
Formula Logic
0.0025*(Age/10)^3 + 0.0615*Spleen + 0.1052*Blasts + 0.4104*(Plt/1000)^-0.5Reference Data
| Risk Group | Score | Probability of Dying of CML |
|---|---|---|
| Low | ≤ 1.5680 | Low |
| Intermediate | 1.5680 - 2.2185 | Intermediate |
| High | > 2.2185 | High |
Evidence-based oncology decision support. Verify with clinical guidelines.